Compliance Strategy for Small to Midsized Companies

February 22, 2013

 

Published for Pharmaceutical Compliance Monitor

On Feb. 20, 2013, Jim Hoover’s article, “Compliance Strategy for Small to Midsized Companies,” published in the online version of Pharmaceutical Compliance Monitor. In the article, Jim discusses the basic steps that small to mid-sized pharmaceutical companies should take when conducting an internal investigation. He instructs  companies to carefully consider the scope and limits of the investigation, who should conduct the investigation, how to protect the relevant privileges, and the possible outcomes of the investigation, prior to conducting the investigation. By fully considering these factors, Jim suggests that companies will be in a better position to correct any problems identified and determine whether or not self-disclosure is warranted. For the full article, please click here.  





Legal Disclaimer:
No representation is made that the quality of services to be performed is greater than the quality of legal services performed by other lawyers.

Featured Attorneys

send article

TESTIMONIALS

  • “Very good.”

    -Chambers 2012

  • “She is very competent in advising us on the deal – many of us didn’t realize the significance or the terminology. She is very thorough and is very good at explaining how the deals worked and what it was.”

    -Chambers 2012

  • "I would recommend him thoroughly.  He is one of my favorite go-to attorneys for financial services litigation."

    - Chambers 2013

  • "...He has written a lot about Alabama employment law. Probably the leader of the group at Burr & Forman.”

    -Chambers 2012

  • "Erich is one of our 'go to' creditors' rights attorneys.  He provides no-nonsense, cost effective legal counsel with exceptional service."

    -Anonymous